Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Organisation › Details

Orexo AB (OMX Nordic List, Mid Cap: ORX)

Orexo is a pharmaceutical company focusing on developing treatments for pain and inflammation. The company has four commercialized products, several projects developed in partnership as well as three proprietary development programs. Orexo's registered products are Abstral® for the treatment of break through cancer pain, sold by Kyowa Hakko Kirin/ProStrakan Group plc. in Europe and in the USA, the sleeping pill Edluar™, sold by Meda in the USA, as well as two products for the diagnosis of Helicobacter pylori which are being marketed by the subsidiary Kibion. *

 

Period Start 1995-01-01 established_pre
  Group Orexo (Group)
  Predecessor Diabact AB
Products Industry drug delivery technology (drug formulation technology)
  Industry 2 diagnostics (medical/biological)
Persons Person Sørensen, Nikolaj (Orexo 201810 CEO joined 201110 as CCO before Pfizer AB + Boston Consulting Group)
  Person 2 Juuel, Henrik (Bavarian Nordic 201811– before Orexo + Virgin Mobile + GN ReSound + NNE Pharmaplan + Novo Nordisk)
     
Region Region Uppsala
  Country Sweden
  Street 32A Virdings allé
  City 751 05 Uppsala
  Tel +46-18-780-8800
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency SEK
  Annual sales 783,100,000 (revenues, net, consolidated (2018) 2018-12-31)
  Profit 137,900,000 (2018-12-31)
  Cash 589,800,000 (2018-12-31)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Orexo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top